Wave Life Sciences Ltd. (WVE) Shareholder/Analyst Call May 18, 2026 5:30 PM EDT
Company Participants
Kate Rausch - Head of Investor Relations
Paul Bolno - President, CEO & Director
Christopher Wright - Chief Medical Officer
Christopher Francis - Senior VP of Corporate Development & Head of Emerging Areas
Conference Call Participants
Kyle Hogarth
Samantha Semenkow - Citigroup Inc., Research Division
Steven Seedhouse - Cantor Fitzgerald & Co., Research Division
Yun Zhong - Wedbush Securities Inc., Research Division
Salim Syed - Mizuho Securities USA LLC, Research Division
Joseph Schwartz - Leerink Partners LLC, Research Division
Alec Stranahan - BofA Securities, Research Division
Catherine Novack - JonesTrading Institutional Services, LLC, Research Division
Madison Wynne El-Saadi - B. Riley Securities, Inc., Research Division
Cheng Li - Oppenheimer & Co. Inc., Research Division
Benjamin Burnett - Wells Fargo Securities, LLC, Research Division
Whitney Ijem - Canaccord Genuity Corp., Research Division
Jiayi Yuan - RBC Capital Markets, Research Division
Michael King - Rodman & Renshaw Research
Cha Cha Yang - Jefferies LLC, Research Division
Alexander Nackenoff - Truist Securities, Inc., Research Division
Presentation
Operator
Hello, and welcome to the Wave Life Sciences RestorAATion-2 Clinical Data Update Conference Call. [Operator Instructions] Also, as a reminder, this conference is being recorded today.
I will now turn the call over to Kate Rausch, Vice President of Corporate Affairs and Investor Relations.
Kate Rausch
Head of Investor Relations
Thank you, operator. This afternoon, we issued a press release announcing a positive update from our ongoing RestorAation-2 trial of WVE-006 in alpha-1 antitrypsin deficiency. Our press release can be found in the Investor Relations section of our website, www.wavelifesciences.com. The slide presentation to accompany this call will be available on the website following the prepared remarks.
Before we begin, I would like to remind you that discussions during this conference call will include forward-looking statements. These statements are subject to a number of risks and uncertainties that could
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。